Skip to main content

Drug for rare condition tested at UAB, gets FDA approval

The drug is marketed as the first treatment for Rett syndrome.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.